Precision Medicine

Precision Medicine

Abstract image featuring a luminous, symmetrical pattern of blue and white swirling lines against a dark background, resembling a cosmic or nebula-like formation.
A look inside Mindstate Design Labs' effort to design drugs that reliably produce specific states of mind.
A gloved hand holds a small vial in front of a colorful, blurred background resembling a DNA sequence.
"The promise of the Human Genome Project has finally arrived."
Illustration of a hand cutting red tape with scissors over a government building labeled "National of Health.
There is one obstacle that reliably blocks innovative ideas: how we fund science.
Fluorescence microscopy image showing a close-up of cells in vibrant blue and green colors, with an arrow indicating a magnified section.
Cancers can’t develop without genetic mutations — or can they?
Transparent perfume bottle surrounded by floating pink spheres with intricate patterns on a dark background.
Vaccines targeting some of our deadliest cancers are showing promise in early trials.
Twin Health lets patients with diabetes see what’s happening inside their own body and can model each patient’s unique metabolism.
An image of a man punching a ball.
They call it “Judo T-cell therapy,” and it’s 100 times more potent than regular CAR-T cells.
A machine is moving down a conveyor belt in a warehouse.
Britain is profiling the genes, health and lifestyles of its citizens and handing the results to scientists across the world.
A rat is floating in front of a DNA screen, exhibiting an autistic behavior.
The study is a solid step toward developing gene therapies against neurodevelopmental disorders.
A lepodisiran image of a human heart on a black background.
There is currently no easy way to treat high Lp(a). A single shot could change that.
An image displaying the periodic table of elements.
Cancer cells hoard iron in unusually high quantities. Scientists have discovered how to leverage this to create safer cancer drugs.
A picture of a dollar bill with a wave pattern.
To put things in perspective, the cost of sequencing a single genome in 2012 was around $10,000.
a collage of images of cell phones and cell phones.
Early, non-aggressive tumors should be called "nodules."
The soft robotic models are patient-specific and could help clinicians zero in on the best implant for an individual.
From the bedside to the lab bench, here’s how laboratory testing works.
biotech trends
From synthetic biology to xenotransplantation, biotech will continue to march forward in 2023, in part powered by data and AI.
Chronotherapeutic drug delivery aims to maximize treatment effectiveness and minimize side effects.
crispr cancer therapy
This small phase 1 study suggests that CRISPR-engineered T cells are safe and potentially effective, but there is a long way to go.
The president identified developing MCED tests as a priority for the Cancer Moonshot.
Close-up illustration of white DNA double helix strands on a green background, highlighting the potential for CRISPR gene-editing technology.
An interview with CRISPR co-discoverer and Nobel Prize-winner Dr. Jennifer Doudna.
John Templeton Foundation
dog cancer vaccine
A successful trial that tested a vaccine against bladder cancer in dogs could help develop a similar one for humans.
A new wave of preventative cancer vaccines are set to begin trials.